Toggle sidebar
Toggle sidebar
全部
智能回答
Search
Search
定价
登录
oncology and aesthetics portfolio
搜索文档
AbbVie Beats Third-Quarter Estimates. There's More to the Drugmaker's Earnings.
Barrons
·
2025-10-31 20:20
公司业绩表现 - 艾伯维肿瘤学和美学产品组合的收入在本季度出现下滑 [1]
艾伯维(US:ABBV)
Pharmaceuticals
oncology and aesthetics portfolio
Pharmaceuticals
oncology and aesthetics portfolio